Navigation Links
Though Vital to Educating Doctors on New Products, Pharma "Med Ed" Groups Working Under Huge Internal & External Constraints
Date:6/18/2013

CHAPEL HILL, N.C., June 18, 2013 /PRNewswire/ -- Recent regulatory and budget challenges have made it more and more difficult for Medical Education groups at large pharmaceutical companies to effectively educate doctors and other healthcare practitioners on the safe and effective use of their new products. With the pressure to reduce budgets mounting within the pharma industry, it is crucial that these "Med Ed" groups find practical, economical methods of reaching healthcare professionals.

To address the changes that are transforming the Medical Education area throughout the healthcare landscape, research and consulting firm Best Practices, LLC developed the critical new study "Benchmarking Critical Program Trends Transforming the Medical Device and Biopharmaceutical Marketplace." This field research investigates emerging trends regarding funding, delivery channels, program effectiveness, and value drivers related to the Medical Education function.

Key study topics include:

  • Funding channels utilized by Medical Education groups
  • Effectiveness of different Medical Education program types and delivery channels
  • Use of multi-disciplinary Medical Education programs
  • Trends in grants to professional societies/associations for accredited and non-accredited education programs 
  • Rating of company professionals most valued by physicians for education
  • Future trends in Medical Education programs and technology

The full 120-page report contains over 500 valuable benchmark metrics that will equip executives with the critical data needed to make informed decisions. The study identifies current program and funding trends that will allow Medical Education leadership to evaluate their organization's resource levels relative to other market leaders.

This benchmarking research drew participation from 32 Medical Education executives and managers from 31 leading global pharmaceutical and medical device companies. In addition, deep-dive interviews were conducted with five selected respondents to gather additional insights.

To learn more about this report, download a complimentary report excerpt by visiting http://www.best-in-class.com/rr1218.htm. For more information on other recent primary research studies, contact us at 919.403.0251, or visit our website at http://www.best-in-class.com/. Check out our new blog at http://whybenchmarking.com/ for more industry trends and topics!

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.

 

 

 


'/>"/>
SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Next Generation Pharmaceutical Manufacturing Summit Pushes the Envelope of Thought-Leadership at its September Summit in London
2. TMG Health To Present Kip Piper at Thought Leadership Dinner
3. GDS Internationals Fourth Next Generation Pharmaceutical Drug Development Summit Attracts an Unprecedented Delegation of Thought Leaders
4. Biotechnology Thought Leader, Dr. Abbie Celniker, Joins ImaginAb Board of Directors as Chairman
5. Agendia Brings Together Thought Leaders in Molecular Diagnostics and Medical Oncology
6. Annai Systems And ThoughtWorks Develop Evidence Engine For The Clearity Foundation To Individualize Options For Treatment Of Ovarian Cancer
7. Longitudinal Study Highlights Evolving Role of Medical Science Liaisons with Thought Leaders and Product Development
8. Though Over One-Third of Rheumatologists Have Prescribed Xeljanz for Their Rheumatoid Arthritis Patients, Physicians are Still Concerned With the Drugs Limited Post-Marketing Experience and Risks of Infection and Malignancy
9. In Pretreated Advanced Renal Cell Carcinoma, Thought Leaders Opinions and Clinical Data Indicate that Tivopath Has Efficacy and Tolerability Advantages Over Currently Used Therapies
10. For Osteoporosis and Osteopenia, Clinical Data and Thought Leaders Opinions Indicate that AMG-785/CDP-7851 and Odanacatib Have Advantages Over Alendronate
11. In Relapsed/Refractory Multiple Myeloma, Thought Leaders Are Optimistic that the Combination of Carfilzomib, Lenalidomide and Dexamethasone Will Be the Most Efficacious Regimen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/13/2017)... According to a new ... by Method (Biochemical (Calcium Phosphate, Lipofection, Dendrimers), Physical ... User - Global Forecast to 2021", published by ... 2016 to 2021. This market is expected to ... 715.4 Million in 2016, at a CAGR of ...
(Date:1/13/2017)... 13, 2017 The 2016 election resulted ... several states voting in favor of legalizing cannabis for recreational ... market in the U.S. In addition, the state of ... annual cannabis products sales. The ArcView Group has published an ... legal cannabis sales in the U.S. last year reached $6.7 billion, ...
(Date:1/13/2017)... YORK , Jan. 12, 2017  Rosen Law ... filing of a class action lawsuit on behalf of ... ALXN ) from February 10, 2014 through November 9, ... recover damages for Alexion investors under the federal securities ... go to http://rosenlegal.com/cases-991.html or call Phillip ...
Breaking Medicine Technology:
(Date:1/16/2017)... ... January 16, 2017 , ... As New York’s fastest ... Giamos, MD to their medical staff, according to eye surgeon, Jeffrey Martin, MD, ... Care, a division of SightMD. Dr. Giamos will practice primarily out of SightMD’s ...
(Date:1/16/2017)... , ... January 16, 2017 , ... St. Louisans are well-aware of the following facts ... This year’s influenza shot seems to be having no effect on keeping this particularly ... half of the people around are coughing, sneezing, or sniffling , These ...
(Date:1/16/2017)... ... 2017 , ... One thing common to all types of cancer is that ... well. The money spent screening for and treating cancer in the United States is ... cancer more than in any other country that has an advanced healthcare system, sometimes ...
(Date:1/15/2017)... , ... January 15, 2017 , ... In this role, ... the United States for the asthma & allergy friendly mark. This certification program was ... test and identify consumer products to be more suitable for the 60+ million people ...
(Date:1/15/2017)... ... ... "On Tour is a music themed slideshow production package which allows editors ... CEO of Pixel Film Studios. , On Tour’s new slide presets come with ... their slideshows. Place each slide on top of another slide or piece of media ...
Breaking Medicine News(10 mins):